ACTRN12621001608853Recruiting未知
Characterising prostate cancer patients undergoing androgen deprivation therapy: Is there a group of men more at risk of cognitive changes? A Cross-sectional Study
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Macquarie University
- Enrollment
- 150
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to o limit (—)
- Sex
- Male
Inclusion Criteria
- •Men aged 18 or older, who are able to read and speak English sufficiently well to respond to written questions and provide consent and have access to an electronic device will be included for the study. There will be three groups of participants:
- •i) Men diagnosed with prostate cancer, who are currently undergoing hormonal treatments (androgen deprivation therapy);
- •ii) Men diagnosed with prostate cancer, who have are on ‘watchful waiting’;
- •iii) Age-matched men without a prostate cancer diagnosis.
Exclusion Criteria
- •Receiving a diagnosis of dementia prior to commencing treatment for prostate cancer.
Investigators
Similar Trials
Not yet recruiting
Phase 2
A continence promotion intervention involving a pelvic floor muscle rehabilitation exercise program to reduce lower urinary tract, lower bowel symptoms and erectile dysfunction in men receiving radiation therapy with or without androgen deprivation therapy (ADT): A Pilot StudyProstate Cancer TreatmentLower Urinary Tract sequelae to radiation therapy with or without androgen deprivation therapyLower Bowel Dysfunction as sequelae to radiation therapy with or without androgen deprivation therapyErectile Dysfunction as sequelae to radiation therapy with or without androgen deprivation therapyCancer - ProstatePhysical Medicine / Rehabilitation - PhysiotherapyRenal and Urogenital - Other renal and urogenital disordersACTRN12612000527864niversity of Newcastle40
Completed
Phase 1
Phase 0 Trial of Gallium-68 tris-hydroxypyridinone prostate specific membrane antigen (Ga-68 THP-PSMA) positron emission tomography (PET) scanning for prostate cancerCancer - Prostateprostate cancerACTRN12615001324505Peter MacCallum Cancer Centre14
Recruiting
Not Applicable
The safety and efficacy of Irreversible Electroporation for the ablation of prostate cancer assessed by procedural related side effects and post prostatectomy histology: A pilot studyCancer - ProstateProstate cancerACTRN12612000523808Flack Trustees6
Completed
Not Applicable
Patient involvement in prostate cancer treatment decisionsCancerProstate cancerISRCTN97145188Dutch Cancer Society (The Netherlands)300
Completed
Not Applicable
The Body concept of prostate carcinoma patientsC61Malignant neoplasm of prostateDRKS00003319Martin-Luther-Universität Halle WittenbergInstitut für Gesundheits- und Pflegewissenschaft339